Lymphagiosarcoma
Reading File
Finding Sources
Finding Sources
Searching PubMed
lymphangiosarcoma Stewart-Treves syndrome
Reading File
Reading File
Reading File
Reading File
Loading Image
Finding Sources
Reading File
Reading File
I now have comprehensive content from multiple authoritative textbooks. Here is the full, detailed answer:
Lymphangiosarcoma (Stewart-Treves Syndrome)
Definition
Lymphangiosarcoma is a rare, highly malignant tumor arising from lymphatic endothelial cells. It is a variant of angiosarcoma, classified under the broader "malignant angioendothelioma" umbrella along with hemangiosarcoma. The eponym Stewart-Treves syndrome specifically refers to lymphangiosarcoma arising in postmastectomy lymphedema, first described by Stewart and Treves in 1948. - Schwartz's Principles of Surgery, 11e, p. 1596
Pathogenesis & Etiology
The key predisposing factor is chronic, long-standing lymphedema (typically >10 years). The underlying mechanism involves:
- Prolonged lymphatic stasis creating an immunologically impaired microenvironment
- Local tissue hypoxia and chronic inflammation promoting malignant endothelial transformation
- The tumor arises from lymphatic endothelium and proliferates rapidly with early systemic spread
Causes of the underlying lymphedema include:
| Cause | Notes |
|---|---|
| Post-mastectomy / axillary node dissection | Classic; occurs in ~0.07% of patients after axillary dissection |
| Postmastectomy + radiation (Stewart-Treves syndrome) | Latency ~10 years; tumor occurs outside radiation field but within the zone of lymphedema |
| Filarial infections | Chronic filariasis causing lower extremity lymphedema |
| Congenital lymphedema | Lower extremity involvement |
| Primary or secondary lymphedema (any cause) | Can affect both upper and lower extremities |
The development of angiosarcoma from radiation therapy alone (with minimal/no lymphedema) is called "cutaneous postradiation angiosarcoma of the breast" - a distinct but related entity. - Sabiston Textbook of Surgery, p. 1294; Andrews' Diseases of the Skin
Clinical Features
- Acute worsening of pre-existing chronic lymphedema
- Appearance of bluish or reddish-purple subcutaneous nodules on the affected extremity (typically the arm in postmastectomy cases)
- Nodules have a propensity toward hemorrhage and ulceration
- Multiple lesions are common
- Rapid proliferation with early systemic metastasis
Figure: Lymphangiosarcoma developing 10 years after breast cancer treatment (Schwartz's Principles of Surgery, 11e)
Immunohistochemistry (Pathology)
Diagnosis is confirmed by tissue biopsy with immunohistochemical staining:
- Positive markers: CD34, CD31, Ulex europaeus lectin (endothelial markers)
- Negative: Antikeratin antibodies (useful to exclude metastatic breast carcinoma, which stains keratin-positive)
This panel differentiates lymphangiosarcoma from metastatic carcinoma in the skin of a patient with breast cancer history. - Andrews' Diseases of the Skin
Prognosis
Extremely poor:
- Average survival after diagnosis: ~19 months
- Early and aggressive metastatic spread is the rule
- Schwartz's Principles of Surgery reports the tumor is "generally aggressive"
Treatment
- Radical surgery - often requires radical amputation of the affected extremity; this may be lifesaving if performed early
- Preoperative chemotherapy - used in the multimodal approach, as for other high-grade sarcomas
- Radiation therapy - combined with surgery in a multimodal approach
- The standard sarcoma approach: neoadjuvant chemoradiation followed by surgical excision is the framework - Sabiston Textbook of Surgery
Related/Differential Entities
| Entity | Key Differentiator |
|---|---|
| Cutaneous postradiation angiosarcoma of breast | From radiation alone, minimal lymphedema, arises in breast |
| Kaposi's sarcoma | HIV/HHV-8 associated, blood vessel endothelium, different distribution |
| Hemangiosarcoma | Arises from blood vascular endothelium (not lymphatic) |
| Metastatic breast carcinoma to skin | Antikeratin positive, CD31/CD34 negative |
Key Facts Summary
- First described: Stewart & Treves, 1948 (6 cases of postmastectomy lymphangiosarcoma)
- Incidence: ~0.07% after axillary node dissection
- Latency: Usually >10 years of chronic lymphedema before malignant transformation
- Site: Most common in the upper extremity (postmastectomy), but can occur in any chronically lymphedematous region
- Predisposing conditions listed by Washington Manual: Age, prior radiation, chemical/chemotherapy exposure, genetic syndromes, Paget's disease of bone, HIV/HHV-8 (Kaposi), and chronic lymphedema (lymphangiosarcoma/Stewart-Treves)
Recent evidence note: A 2025 systematic review on MRI features of Stewart-Treves syndrome (PMID 39907978, Jpn J Radiol, Jun 2025) provides updated imaging characterization - worth consulting if radiological diagnosis is relevant to your context.
This is a shared conversation. Sign in to Orris to start your own chat.